Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled Administration
- 8 March 1995
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 35 (3), 302-305
- https://doi.org/10.1002/j.1552-4604.1995.tb04064.x
Abstract
The pharmacokinetics of triamcinolone acetonide were studied after intravenous (2 mg), oral (5 mg), and inhaled (2 mg) administration. Triamcinolone acetonide concentrations were measured in plasma by high‐performance liquid chromatography/radioimmunoassay. After intravenous administration, triamcinolone acetonide was eliminated with a total body clearance of 37 L/h and a half‐life of 2.0 hours. The volume of distribution was 103 L, and oral bioavailability averaged 23%. Absorption was rapid, achieving maximum triamcinolone acetonide levels of 10.5 ng/mL after 1 hour. After inhalation, bioavailability averaged 22% with maximum levels of 2.0 ng/mL observed after 2.1 hours. The resulting systemic levels for all three treatments caused a significant decrease in the number of lymphocytes in blood.Keywords
This publication has 4 references indexed in Scilit:
- Inhaled Corticosteroids in Asthma: A Dose‐Proportionality Study with Triamcinolone Acetonide AerosolThe Journal of Clinical Pharmacology, 1992
- Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administrationClinical Pharmacology & Therapeutics, 1986
- Aerosol Deposition Considerations in Inhalation TherapyChest, 1985
- Pharmacokinetics of triamcinolone acetonide and its phosphate esterEuropean Journal of Clinical Pharmacology, 1985